Stoneridge Investment Partners LLC Vertex Pharmaceuticals Inc Transaction History

Stoneridge Investment Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$273.83 - $305.53 $233,029 - $260,006	-851 Reduced 42.66%	1,144 $331,000
Q2 2022 Aug 01, 2022	BUY	$234.96 - $292.55 $468,745 - $583,637	1,995 New	1,995 $562,000
Q1 2022 Apr 26, 2022	SELL	$221.42 - $260.97 $251,975 - $296,983	-1,138 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$177.01 - $223.45 $460,226 - $580,970	-2,600 Reduced 69.56%	1,138 $250,000
Q3 2021 Nov 03, 2021	BUY	$181.39 - $202.99 $281,154 - $314,634	1,550 Added 70.84%	3,738 $678,000
Q1 2021 Apr 30, 2021	BUY	$207.02 - $241.31 $93,159 - $108,589	450 Added 25.89%	2,188 $470,000
Q4 2020 Feb 02, 2021	BUY	$207.01 - $276.09 $359,783 - $479,844	1,738 New	1,738 $411,000

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Stoneridge Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Stoneridge Investment Partners LLC with notifications on news.